Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Status:
Completed
Trial end date:
2018-05-14
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy (RT) uses high-energy x-rays to damage tumor cells. Androgens
can stimulate the growth of prostate cancer cells. Hormone therapy using flutamide,
goserelin, and leuprolide may fight prostate cancer by reducing the production of androgens.
It is not yet known which regimen of antiandrogen therapy is most effective for prostate
cancer.
PURPOSE: Randomized phase III trial to study the effectiveness of radiation therapy with or
without antiandrogen therapy in treating patients who have stage I or stage II prostate
cancer.